Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

529 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differential effects of renin-angiotensin-aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension: a double-blind, placebo-controlled cross-over trial.
Dorresteijn JA, Schrover IM, Visseren FL, Scheffer PG, Oey PL, Danser AH, Spiering W. Dorresteijn JA, et al. Among authors: visseren fl. J Hypertens. 2013 Feb;31(2):393-403. doi: 10.1097/HJH.0b013e32835b6c02. J Hypertens. 2013. PMID: 23235355 Clinical Trial.
[Sensory disturbances caused by multivitamin preparations].
Spiering W, Visseren FL. Spiering W, et al. Among authors: visseren fl. Ned Tijdschr Geneeskd. 2006 Feb 4;150(5):277; author reply 277. Ned Tijdschr Geneeskd. 2006. PMID: 16494000 Dutch. No abstract available.
Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.
Hajer GR, Dallinga-Thie GM, van Vark-van der Zee LC, Olijhoek JK, Visseren FL. Hajer GR, et al. Among authors: visseren fl. Clin Endocrinol (Oxf). 2008 Dec;69(6):870-7. doi: 10.1111/j.1365-2265.2008.03250.x. Epub 2008 Apr 3. Clin Endocrinol (Oxf). 2008. PMID: 18394022 Clinical Trial.
The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.
Olijhoek JK, Hajer GR, van der Graaf Y, Dallinga-Thie GM, Visseren FL. Olijhoek JK, et al. Among authors: visseren fl. J Cardiovasc Pharmacol. 2008 Aug;52(2):145-50. doi: 10.1097/FJC.0b013e31817ffe76. J Cardiovasc Pharmacol. 2008. PMID: 18670365 Clinical Trial.
Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy.
Westerweel PE, Visseren FL, Hajer GR, Olijhoek JK, Hoefer IE, de Bree P, Rafii S, Doevendans PA, Verhaar MC. Westerweel PE, et al. Among authors: visseren fl. Eur Heart J. 2008 Nov;29(22):2808-17. doi: 10.1093/eurheartj/ehn431. Epub 2008 Sep 28. Eur Heart J. 2008. PMID: 18824462 Clinical Trial.
529 results